Ultracet Generics Launch: Par Goes "At Risk," Ivax Has "Authorized" Generic
This article was originally published in The Pink Sheet Daily
Executive Summary
Patent litigation between Par and J&J is pending in Newark, N.J. federal court. Par received ANDA approval for the tramadol/acetaminophen combination the same day the 30-month stay expired.